scholarly journals Scaffold strategies combined with mesenchymal stem cells in vaginal construction: a review

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Nicole Andréa Corbellini Henckes ◽  
Dalana Faleiro ◽  
Laura Chao Chuang ◽  
Elizabeth Obino Cirne-Lima

AbstractTissue engineering has provided new treatment alternatives for tissue reconstruction. Advances in the tissue engineering field have resulted in mechanical support and biological substitutes to restore, maintain or improve tissue/organs structures and functions. The application of tissue engineering technology in the vaginal reconstruction treatment can not only provide mechanical requirements, but also offer tissue repairing as an alternative to traditional approaches. In this review, we discuss recent advances in cell-based therapy in combination with scaffolds strategies that can potentially be adopted for gynaecological transplantation.

2020 ◽  
Vol 8 (21) ◽  
pp. 6069-6081
Author(s):  
Ao Xiong ◽  
Yijun He ◽  
Liang Gao ◽  
Guoqing Li ◽  
Jian Weng ◽  
...  

Over the past few years, tissue-engineering technology provided a new direction for bone defects therapy, which involved developing applicable biological materials composite with seed cells to repair bone defects tissue.


2021 ◽  
Vol 12 (07) ◽  
pp. 5-13
Author(s):  
Elcin Nizami Huseyn ◽  

Tissue engineering technology and tissue cell-based stem cell research have made great strides in treating tissue and organ damage, correcting tissue and organ dysfunction, and reducing surgical complications. In the past, traditional methods have used biological substitutes for tissue repair materials, while tissue engineering technology has focused on merging sperm cells with biological materials to form biological tissues with the same structure and function as their own tissues. The advantage is that tissue engineering technology can overcome donors. Material procurement restrictions can effectively reduce complications. The aim of studying tissue engineering technology is to find sperm cells and suitable biological materials to replace the original biological functions of tissues and to establish a suitable in vivo microenvironment. This article mainly describes the current developments of tissue engineering in various fields of urology and discusses the future trends of tissue engineering technology in the treatment of complex diseases of the urinary system. The results of the research in this article indicate that while the current clinical studies are relatively few, the good results from existing animal model studies indicate good prospects of tissue engineering technology for the treatment of various urinary tract diseases in the future. Key words: Tissue engineering, kidney, ureter, bladder, urethra


RSC Advances ◽  
2019 ◽  
Vol 9 (21) ◽  
pp. 11882-11893
Author(s):  
Yang Li ◽  
Yu Zhang ◽  
Jing-Li Ding ◽  
Ji-Chun Liu ◽  
Jian-Jun Xu ◽  
...  

A novel composite valve with controlled release OPG was prepared by introducing tissue engineering technology and nano drug-loading system to introduce anti-calcification biological factor OPG on the decellularized valve.


Materials ◽  
2020 ◽  
Vol 13 (13) ◽  
pp. 2891
Author(s):  
Pilar Simmons ◽  
Taylor McElroy ◽  
Antiño R. Allen

Artificial extracellular matrices (aECMs) are an extension of biomaterials that were developed as in-vitro model environments for tissue cells that mimic the native in vivo target tissues’ structure. This bibliometric analysis evaluated the research productivity regarding aECM based on tissue engineering technology. The Web of Science citation index was examined for articles published from 1990 through 2019 using three distinct aECM-related topic sets. Data were also visualized using network analyses (VOSviewer). Terms related to in-vitro, scaffolds, collagen, hydrogels, and differentiation were reoccurring in the aECM-related literature over time. Publications with terms related to a clinical direction (wound healing, stem cells, artificial skin, in-vivo, and bone regeneration) have steadily increased, as have the number of countries and institutions involved in the artificial extracellular matrix. As progress with 3D scaffolds continues to advance, it will become the most promising technology to provide a therapeutic option to repair or replace damaged tissue.


2009 ◽  
Vol 13 (8a) ◽  
pp. 1417-1427 ◽  
Author(s):  
Dietmar W. Hutmacher ◽  
Raymund E. Horch ◽  
Daniela Loessner ◽  
Simone Rizzi ◽  
Shirly Sieh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document